All Cosmos Bio-Tech Holding Second Quarter 2024 Earnings: EPS: NT$0.12 (vs NT$0.61 in 2Q 2023)

Simply Wall St · 09/01 02:45

All Cosmos Bio-Tech Holding (TWSE:4148) Second Quarter 2024 Results

Key Financial Results

  • Revenue: NT$478.4m (down 39% from 2Q 2023).
  • Net income: NT$7.96m (down 80% from 2Q 2023).
  • Profit margin: 1.7% (down from 4.9% in 2Q 2023). The decrease in margin was driven by lower revenue.
  • EPS: NT$0.12 (down from NT$0.61 in 2Q 2023).
earnings-and-revenue-history
TWSE:4148 Earnings and Revenue History September 1st 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

All Cosmos Bio-Tech Holding shares are down 2.6% from a week ago.

Risk Analysis

It's still necessary to consider the ever-present spectre of investment risk. We've identified 3 warning signs with All Cosmos Bio-Tech Holding, and understanding them should be part of your investment process.